Isochenodeoxycholic acid

Isochenodeoxycholic acid (isoCDCA) is a human fecal bile acid. Isochenodeoxycholic acid has cytoprotective against ethanol-induced cell injuries in HepG2 cells. Isochenodeoxycholic acid is a major metabolite of orally administered ursodeoxycholic acid (UDCA) [1].

Product Specifications

CAS Number

[566-24-5]

Product Name Alternative

IsoCDCA

UNSPSC

12352211

Hazard Statement

H301+H311+H331

Target

Drug Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/isochenodeoxycholic-acid.html

Purity

99.88

Solubility

DMSO : 100 mg/mL (ultrasonic) |Ethanol : 8.33 mg/mL (ultrasonic)

Smiles

C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(O)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](C[C@H](CC4)O)([H])C[C@H]3O)C

Molecular Formula

C24H40O4

Molecular Weight

392.57

Precautions

H301+H311+H331

References & Citations

[1]Marschall HU, et al. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis. J Lipid Res. 2001 May;42 (5) :735-42.